RxSight, Inc. (RXST)
RxSight has a market cap or net worth of $553.92 million. The enterprise value is $492.35 million.
The next earnings date is Thursday, May 4, 2023, after market close.
|Estimated Earnings Date||May 4, 2023|
RxSight has 33.78 million shares outstanding. The number of shares has increased by 103.02% in one year.
|Shares Change (YoY)||+103.02%|
|Shares Change (QoQ)||+1.19%|
|Owned by Insiders (%)||17.82%|
|Owned by Institutions (%)||41.89%|
|EV / Earnings||n/a|
|EV / Sales||10.05|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 7.81, with a Debt / Equity ratio of 0.50.
|Debt / Equity||0.50|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -63.70% and return on invested capital (ROIC) is -35.30%.
|Return on Equity (ROE)||-63.70%|
|Return on Assets (ROA)||-41.10%|
|Return on Capital (ROIC)||-35.30%|
|Revenue Per Employee||$221,742|
|Profits Per Employee||-$302,063|
In the past 12 months, RxSight has paid $9,000 in taxes.
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has increased by +33.75% in the last 52 weeks.
|52-Week Price Change||+33.75%|
|50-Day Moving Average||14.09|
|200-Day Moving Average||13.33|
|Average Volume (30 Days)||138,456|
Short Selling Information
The latest short interest is 400,099, so 1.18% of the outstanding shares have been sold short.
|Short Previous Month||405,232|
|Short % of Shares Out||1.18%|
|Short % of Float||1.95%|
|Short Ratio (days to cover)||2.80|
In the last 12 months, RxSight had revenue of $49.01 million and -$66.76 million in losses. Loss per share was -$2.41.
|Loss Per Share||-$2.41|
The company has $106.56 million in cash and $45.00 million in debt, giving a net cash position of $61.57 million or $1.82 per share.
|Cash & Cash Equivalents||106.56M|
|Net Cash Per Share||$1.82|
|Equity / Book Value||89.90M|
|Book Value Per Share||2.66|
In the last 12 months, operating cash flow was -$58.85 million and capital expenditures -$2.39 million, giving a free cash flow of -$61.24 million.
|Operating Cash Flow||-58.85M|
|Free Cash Flow||-61.24M|
|FCF Per Share||-$2.21|
Gross margin is 43.52%, with operating and profit margins of -129.21% and -136.22%.
Dividends & Yields
RxSight does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for RxSight is $19.79, which is 20.67% higher than the current price. The consensus rating is "Buy".
|Price Target Difference||20.67%|
|Revenue Growth Forecast (5Y)||36.77%|
|EPS Growth Forecast (5Y)||-25.96%|
This stock does not have any record of stock splits.
|Last Split Date||n/a|